Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

MSC (mesenchymal stem cell) injection as well as preparation and application thereof

A technology of mesenchymal stem cells and injections, applied in the field of preparation of mesenchymal stem cell injections, can solve the problems of short cell viability maintenance time, inconvenient transportation and storage, etc., to prevent cell aggregation, maintain normal metabolic ability, and composition clear effect

Inactive Publication Date: 2015-08-26
北京青藤谷禧干细胞科技研究院有限公司
View PDF2 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The cell viability of the above-mentioned mesenchymal stem cell injection after cryopreservation is short, which is inconvenient for transportation and storage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • MSC (mesenchymal stem cell) injection as well as preparation and application thereof
  • MSC (mesenchymal stem cell) injection as well as preparation and application thereof
  • MSC (mesenchymal stem cell) injection as well as preparation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1: Preparation of umbilical cord mesenchymal stem cells

[0054] The preparation of umbilical cord mesenchymal stem cells comprises the following steps:

[0055] (1) Take fresh umbilical cords taken by cesarean section that have left the mother’s body for no more than 2 hours, and check whether the puerpera is carrying infectious disease pathogens (negative hepatitis B surface antigen, hepatitis C antibody, syphilis antibody, and AIDS antibody), and place the fresh umbilical cord containing D- In the special storage bottle of Hanks balance solution, it is transported in a low-temperature ice box;

[0056] (2) Put the umbilical cord in a biosafety cabinet for ultraviolet irradiation for 30 minutes, preheat the water-bath shaker at 37°C in advance, and place the umbilical cord sample bottle in the biosafety cabinet for operation. Take out the sample with long hemostatic forceps and place it in a 150mm sterile glass dish, and wash away the blood on the surface of ...

Embodiment 2

[0065] Example 2: Preparation of Umbilical Cord Mesenchymal Stem Cell Injection

[0066] Described cryopreservation solution comprises following components:

[0067]

[0068] (1) Take Bomaili A injection, 20% human serum albumin, hydroxyethyl starch 130 / 0.4 and adenosine triphosphate-disodium magnesium chloride freeze-dried powder according to the above formula, and mix them;

[0069] (2) Filter the mixed solution in step (1) with a 0.22 μm bacterial filter, then add the prepared umbilical cord mesenchymal stem cells, and the concentration is controlled at 5×10 6 cells / ml, cell suspension was obtained;

[0070] (3) Add clinical-grade DMSO to the cell suspension in step (2), and pack in In the cell cryopreservation bag, the mesenchymal stem cell injection was obtained.

Embodiment 3

[0071] Example 3: Preparation of Umbilical Cord Mesenchymal Stem Cell Injection

[0072]

[0073] The preparation method was as in Example 2, and the concentration of umbilical cord mesenchymal stem cells was controlled at 8×10 6 pieces / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biology, in particular to MSC (mesenchymal stem cell) injection as well as a preparation and an application thereof. The injection comprises MSCs and a cell cryopreservation solution, wherein the cryopreservation solution comprises components in percentage by volume as follows: 25%-70% of an electrolyte balance solution, 5%-20% of clinical-grade DMSO (dimethyl sulfoxide), 1%-50% of 20% human serum albumin, 1%-10% of hydroxyethyl starch 130 / 0.4 and 5%-20% of triphosadenine-disodium magnesium chloride freeze-drying powder. The injection is free of animal serum, has clear ingredients and good cell cryopreservation effect and is safe and controllable, long-term storage and long-distance transport are facilitated, the survival rate of cells after recovery is higher than 95%, the vitality is high, and the injection can effectively relieve injury and inflammation symptoms of lesion tissue of lungs and promote tissue regeneration of the lungs, so that acute lung injury can be fundamentally and comprehensively treated.

Description

technical field [0001] The invention relates to the field of biology, in particular to a mesenchymal stem cell injection, a preparation method and an application thereof. Background technique [0002] In the 1960s, acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) were recognized as a severe acute respiratory failure syndrome, mainly manifested as hypoxemia , Severe acute respiratory failure with bilateral lung infiltration, common in pneumonia, sepsis, and major trauma. The pathogenesis of ALI / ARDS involves damage to the pulmonary vascular endothelium, damage to the alveolar epithelium, and accumulation of protein-rich exudates and cellular debris in the alveolar spaces. The current treatment plan for ALI / ARDS is mainly supportive treatment, giving lung protective ventilation and conservative drug treatment, and a large number of therapeutic drugs evaluated in clinical trials so far, such as inhaled surfactants, NO, glucocorticoids, ketocon None of az...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61K9/08A61K47/42A61P11/00
Inventor 孙磊孙萍宋亚昆马世泽史振生吴东颖
Owner 北京青藤谷禧干细胞科技研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com